Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Clinical trial NCT01442038 · COMPLETED

Trial details

NCT number: NCT01442038
Sponsor: Gilead Sciences
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Coronary Artery Disease Angina Pectoris

Start date: 2011-10-01
Primary completion: 2015-02-01
Enrollment: 2651

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.